DANCR and neoplasm: Recent studies have implicated that DANCR might act as an oncogenic lncRNA in tumor progression such as hepatocellular carcinoma18,22, prostate cancer23, colorectal cancer24, glioma25, gastric cancer26, osteosarcoma27, lung adenocarcinoma28.